Obesity and Antibiotic Tissue Concentration
NCT00980486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2010-10-08
Summary
The purpose of this study is to determine whether the dose of prophylactic antibiotics at the time of cesarean delivery requires adjustment in obese and overweight patients in order to achieve optimal antimicrobial activity.
Conditions
Sponsors & Collaborators
-
University of California, Irvine
collaborator OTHER -
MemorialCare
lead OTHER
Principal Investigators
-
Kenneth Chan, MD · Long Beach Memorial Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
Timing of Antibiotic Prophylaxis for Cesarean Deliveries
NCT00805545 ·Status: COMPLETED ·Phase: NA
-
Peri-operative Cefazolin Prophylaxis at Time of Cesarean Delivery in the Obese Gravida
NCT01904500 ·Status: COMPLETED ·Phase: PHASE1
-
Trial Comparing the Optimal Timing of Antibiotic Prophylaxis at the Time of Cesarean Delivery
NCT00811603 ·Status: COMPLETED ·Phase: PHASE3
-
Incidence of Complications Associated With Anesthesia in Obesity Parturient Undergoing Cesarean Delivery
NCT04657692 ·Status: COMPLETED
-
Use of Negative Pressure Wound Therapy in Morbidly Obese Women After Cesarean Delivery
NCT03269968 ·Status: TERMINATED ·Phase: NA
-
Inflammation in Obese Parturients: Surgical Outcomes After Elective Caesarean Section
NCT01836315 ·Status: COMPLETED
-
Quality of Recovery Scores in Parturients With Obesity
NCT04988893 ·Status: COMPLETED
-
no Antibiotics for Elective Cesarean With Low Risk of Infection
NCT02126228 ·Status: COMPLETED
-
Antimicrobial Dressing Versus Standard Dressing in Obese Women Undergoing Cesarean Delivery
NCT03887299 ·Status: COMPLETED ·Phase: PHASE4
-
Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery
NCT01755026 ·Status: COMPLETED ·Phase: PHASE4
-
Missing Microbes in Infants Born by Cesarean Section
NCT04134819 ·Status: RECRUITING
-
Opioid Prescription After Cesarean Trial
NCT04296396 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery
NCT03007706 ·Status: UNKNOWN
-
Obesity Among Young Adult Males Born With Cesarean Section.
NCT03918044 ·Status: COMPLETED
-
Outcomes After the Implementation of a New Oxytocin Protocol
NCT02722356 ·Status: COMPLETED ·Phase: NA
-
Timing of Maternal Antibiotic Prophylaxis During a Cesarean Section and the Early Infant Gut Microbiome
NCT06030713 ·Status: COMPLETED ·Phase: NA
-
Ambulation With Labor Epidural in Obese Women
NCT04504682 ·Status: TERMINATED ·Phase: NA
-
Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
NCT05333731 ·Status: UNKNOWN
-
Understanding the Postpartum Pain Experience in Women of Minority Race/Ethnicity
NCT04601246 ·Status: COMPLETED
-
The Timing of Prophylactic Antibiotics in Cesarean Section and the Risk of Post-operative Febrile Morbidity
NCT00133029 ·Status: TERMINATED ·Phase: PHASE4
-
Antibiotic Prophylaxis and Nausea and Vomiting in Cesarean Section Under Regional Anesthesia.
NCT04697277 ·Status: UNKNOWN ·Phase: PHASE4
-
Self-Retaining Retractor in Obese Patients Undergoing Cesarean Section
NCT01826604 ·Status: COMPLETED ·Phase: NA
-
Anesthetic Considerations for Repeat Cesarean Section - a Prospective Study
NCT04693572 ·Status: UNKNOWN
-
Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2
NCT03957083 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Fever Occurring in Labor in Patients Receiving Epidural Anesthesia
NCT00326521 ·Status: UNKNOWN